Zobrazeno 1 - 10
of 848
pro vyhledávání: '"Peter Vestergaard"'
Autor:
Camilla H. N. Thomsen, Jannie T. D. Nørlev, Stine Hangaard, Morten H. Jensen, Ole Hejlesen, Sarah R. Cohen, Allan Kofoed-Enevoldsen, Sika N. S. Kristensen, Tinna B. Aradóttir, Anne Kaas, Peter Vestergaard, Thomas Kronborg
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Diabetes affects 10.5% of adults globally, with type 2 diabetes accounting for 90–95% of cases. Achieving optimal glycemic control is crucial yet challenging, particularly with insulin therapy, where 30–50% of patients fail to
Externí odkaz:
https://doaj.org/article/e5cbb1dfaf614af6a8564c04c28c2b5d
Autor:
Signe Graungaard, Liva Bundgaard Larsen, Peter Vestergaard, Niels Henrik Bruun, Astrid Ditte Højgaard, Jakob Dal
Publikováno v:
Clinical Nutrition Open Science, Vol 57, Iss , Pp 99-108 (2024)
Summary: Background & aims: Accurate fat mass (FM) and muscle mass (MM) assessment is an informative marker of an individual's health. However, the optimal method for assessing body composition in transgender men remains to be determined. Here, we ai
Externí odkaz:
https://doaj.org/article/a0c9885aaca94c13847f3190d8e9fb16
Autor:
Sisse H. Laursen, Iben Engelbrecht Giese, Flemming W. Udsen, Ole K. Hejlesen, Pernille F. Barington, Morten Ohrt, Peter Vestergaard, Stine Hangaard
Publikováno v:
Pilot and Feasibility Studies, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Background Maintaining optimal glycemic control in type 2 diabetes (T2D) is difficult. Telemedicine has the potential to support people with poorly regulated T2D in the achievement of glycemic control, especially if the telemedicine solution
Externí odkaz:
https://doaj.org/article/3d024b697df84f3e83d7c85f9c0a1d6d
Autor:
Nynne Sophie Holdt‐Caspersen, Claus Dethlefsen, Peter Vestergaard, Ole Hejlesen, Stine Hangaard, Morten Hasselstrøm Jensen
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 2, Pp n/a-n/a (2024)
Abstract The adherence to oral antidiabetic drugs (OADs) among people with type 2 diabetes (T2D) is suboptimal. However, new OADs have been marketed within the last 10 years. As these new drugs differ in mechanism of action, treatment complexity, and
Externí odkaz:
https://doaj.org/article/b893abcca6f540a6b461e9c5664f83c7
Autor:
Sisse H. Laursen, Lise Boel, Lisbet Brandi, Jeppe H. Christensen, Peter Vestergaard, Ole K. Hejlesen
Publikováno v:
Experimental Physiology, Vol 108, Iss 10, Pp 1325-1336 (2023)
Abstract A coagulation component should be considered in phosphate kinetics modelling because intradialytic coagulation of the extracorporeal circuit and dialyser might reduce phosphate removal in haemodialysis. Thus, the objective of this study was
Externí odkaz:
https://doaj.org/article/32838c6d9a3741bfac306e7bbba66612
Autor:
Nikki C. C. Werkman, Johanna H. M. Driessen, Coen D. A. Stehouwer, Peter Vestergaard, Nicolaas C. Schaper, Joop P. van den Bergh, Johannes T. H. Nielen
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Background Numerous studies have investigated the potential association of sodium-glucose co-transporter-2 inhibitors (SGLT2-Is) with an increased risk of lower limb amputations (LLAs), but have produced conflicting results. Particularly stu
Externí odkaz:
https://doaj.org/article/a3f95621d14c45b382e75bef4239e4b7
Autor:
Jonas D. Andersen, Carsten W. Stoltenberg, Morten H. Jensen, Peter Vestergaard, Ole Hejlesen, Stine Hangaard
Publikováno v:
Diabetes Epidemiology and Management, Vol 13, Iss , Pp 100190- (2024)
Aims: To describe the incidence of type 1 diabetes (T1D), and incidence of comorbidities in addition to T1D, in adults over a 22-year period in Denmark and explore the associations between socioeconomic status (SES) and the development of comorbiditi
Externí odkaz:
https://doaj.org/article/a71596d840944837917a37010f6a6158
Autor:
Julie Schjødtz Hansen, Fernando Boix, Jørgen Bo Hasselstrøm, Lambert Kristiansen Sørensen, Mads Kjolby, Stefan Gustavsen, Rikke Middelhede Hansen, Thor Petersen, Finn Sellebjerg, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Eva Aggerholm Sædder, Kristina Bacher Svendsen
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Information on the pharmacokinetics (PK) and pharmacodynamics (PD) of orally administered cannabis‐based medicine (CBM) in capsule formulation in patient populations is sparse. In this exploratory study, we aimed to evaluate the PK and PD
Externí odkaz:
https://doaj.org/article/10dc6ec2cd884a1fa87cd0080298e519
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundHypoparathyroidism following total thyroidectomy is globally the most common complication to thyroid surgery. The reported complication rates vary widely and might be highly dependent on the surgical experience. In this study we aimed to ev
Externí odkaz:
https://doaj.org/article/6f9a397cf32e4195bd166cfd186b644d
Autor:
Tim Spelman, Melinda Magyari, Helmut Butzkueven, Anneke Van Der Walt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J. Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Henrik Mathiesen, Jan Hillert, The Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundTreatment switching is a common challenge and opportunity in real-world clinical practice. Increasing diversity in disease-modifying treatments (DMTs) has generated interest in the identification of reliable and robust predictors of treatme
Externí odkaz:
https://doaj.org/article/3d52ca1fdc794fa48cba7a9cc328885d